Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Baxter International Inc.    BAX

BAXTER INTERNATIONAL INC.

(BAX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Baxter International : to Present at the 9th Annual SVB Leerink Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
01/15/2020 | 04:33pm EST

PDF

DEERFIELD, Ill. - January 15, 2020

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 9th Annual SVB Leerink Global Healthcare Conference in New York, N.Y. on Wednesday, February 26, 2020. José (Joe) E. Almeida, Baxter's chairman and chief executive officer, is scheduled to present at 9:30 a.m. Eastern Time.

The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through May 26, 2020.

About Baxter

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.comand follow us on Twitter, LinkedInand Facebook.

Disclaimer

Baxter International Inc. published this content on 15 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 January 2020 21:32:03 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on BAXTER INTERNATIONAL INC.
02/19BAXTER INTERNATIONAL : to Present at the Raymond James 41st Annual Institutional..
BU
02/18BAXTER INTERNATIONAL : Declares Quarterly Dividend
BU
02/18BAXTER INTERNATIONAL : Completes Acquisition of Seprafilm Adhesion Barrier
BU
02/14BAXTER INTERNATIONAL INC. : Report
CO
02/13BAXTER INTERNATIONAL : Expects Restatement to Cut Income From Continuing Operati..
DJ
02/13BAXTER INTERNATIONAL INC : Non-Reliance on Previous Financials, Audits or Interi..
AQ
02/12BAXTER INTERNATIONAL : and COSMED Announce U.S. FDA 510(k) Clearance of Q-NRG+ I..
BU
02/11BAXTER INTERNATIONAL : BT Mobile Launches Samsung Galaxy S20, S20 5G and S20+ 5G..
PU
02/10BAXTER INTERNATIONAL INC. : Report
CO
02/04BAXTER INTERNATIONAL : and Spectral Medical Announce Exclusive Distribution Agre..
AQ
More news
Financials (USD)
Sales 2019 11 338 M
EBIT 2019 2 084 M
Net income 2019 1 677 M
Debt 2019 1 646 M
Yield 2019 0,94%
P/E ratio 2019 29,2x
P/E ratio 2020 24,7x
EV / Sales2019 4,06x
EV / Sales2020 3,87x
Capitalization 44 413 M
Chart BAXTER INTERNATIONAL INC.
Duration : Period :
Baxter International Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAXTER INTERNATIONAL INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 94,47  $
Last Close Price 86,99  $
Spread / Highest target 25,3%
Spread / Average Target 8,60%
Spread / Lowest Target -16,1%
EPS Revisions
Managers
NameTitle
José E. Almeida Chairman, President & Chief Executive Officer
Scott Pleau Senior Vice President-Operations
James K. Saccaro Chief Financial Officer & Executive Vice President
Paul E. Martin Chief Information Officer & Vice President
Sumant Ramachandra Senior VP, Chief Science & Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
BAXTER INTERNATIONAL INC.4.03%44 413
MEDTRONIC PLC-1.85%149 297
HOYA CORPORATION3.55%34 616
ZIMMER BIOMET HOLDINGS0.03%31 854
DEXCOM, INC.29.82%26 933
TERUMO CORPORATION1.42%25 668